Guidelines for drug levels of vancomycin/aminoglycoside
Farrington, E.
Pediatric Nursing 16(1): 64-65
1990
ISSN/ISBN: 0097-9805 PMID: 2359626 Document Number: 361157
Document emailed within 1 workday
Related Documents
Shovick, V.A. 1989: Reguisition forms for serum aminoglycoside or vancomycin concentration determinations American Journal of Hospital Pharmacy 46(8): 1547-1548Pauly, D.J.; Musa, D.M.; Lestico, M.R.; Lindstrom, M.J.; Hetsko, C.M. 1990: Risk of nephrotoxicity with combination vancomycin-aminoglycoside antibiotic therapy PharmacoTherapy 10(6): 378-382
Corso, A.; Galas, M.F.; Rossi, M.A. 1996: Determination of serum aminoglycoside and vancomycin concentrations by the microbiological method in the presence of other antimicrobials Revista Argentina de Microbiologia 28(3): 123-131
Mümtaz Cem Şirin; Adilo, A.K.ğlu 2011: Comparison of Five Antimicrobial Susceptibility Tests in Detecting High Level Aminoglycoside and Vancomycin Resistances in Hospital Acquired Enterococcus Isolates Clinical Laboratory 57(3-4): 157-162
Fogarty, K.A.; McClain, W.J. 1989: Vancomycin: current perspectives and guidelines for use in the NICU Neonatal Network: Nn 7(5): 31-35
Reesor Nimmo, C.; Mamdani, F.; Baker, A.; Jewesson, P. 1993: Development and implementation of simplified aminoglycoside empiric dosing guidelines PharmacoTherapy 13(4): 408-414
Lancon, J.P.; Honnart, D.; Freysz, M.; Dumas, M. 1985: Serum aminoglycoside levels Critical Care Medicine 13(11): 995-996
McCormack, J.P. 2012: No evidence base for monitoring aminoglycoside levels Bmj 345: E7264; Author Reply E7265
Sauer, P.; Síla, J.; Vágnerová, I. 2009: Virulence factors in vancomycin-susceptible and vancomycin-resistant enterococci in the University Hospital Olomouc Klinicka Mikrobiologie a Infekcni Lekarstvi 15(2): 44-47
Hortin, G.L.; Landt, M.; Wilhite, T.; Smith, C.H. 1991: Cross-reactivity of a vancomycin degradation product in three immunoassays of vancomycin Clinical Chemistry 37(11): 2009
Walczyk, M.H.; Hill, D.; Arai, A.; Wolfson, M. 1988: Acute renal failure owing to inadvertent vancomycin overdose. Vancomycin removal by continuous arteriovenous hemofiltration Annals of Clinical and Laboratory Science 18(6): 440-443
Ollagnier, M.; Guy, C. 1988: Aminoglycoside-induced nephrotoxicity. Evaluation of drug surveillance centers Therapie 43(5): 405-406
Zeng, M.; Yi, Q.; Zeng, L.; Chen, Z.; Mi, X.; Song, H.; Zhang, X.; Li, Y.; Wang, Q.; Zhao, R.; Miao, L.; Zhang, L. 2020: Quality of therapeutic drug monitoring guidelines is suboptimal: an evaluation using the Appraisal of Guidelines for Research and Evaluation II instrument Journal of Clinical Epidemiology 120: 47-58
Pandya, A.P.; Sharma, R.S.; Sahu, G.C. 1995: An analytical presentation of drug resistance in Plasmodium falciparum and guidelines to formulate a drug strategy Journal of Communicable Diseases 27(1): 44-54
Brouard, S.; Lelan, J.; Lancien, G.; Bonnaure, M.; Cormier, M.; Langlais, F. 1997: Tricalcium phosphate, vector of antibiotics: gentamycin and vancomycin. in vitro physicochemical characterization, study of biomaterial porosity and gentamycin and vancomycin elution Chirurgie; Memoires de l'Academie de Chirurgie 122(7): 397-403
Matzke, G.R.; Kovarik, J.M.; Rybak, M.J.; Boike, S.C. 1985: Evaluation of the vancomycin-clearance:creatinine-clearance relationship for predicting vancomycin dosage Clinical Pharmacy 4(3): 311-315
Fabre, J.; de Sousa, R. 1980: Aminoglycoside nephrotoxicity. II. Transtubular transport and factors modifying aminoglycoside nephrotoxicity Nephrologie 1(2): 89-94
Junod, A.F. 2009: The development of guidelines and their lower levels of evidence Revue Medicale Suisse 5(206): 1284
Schleifer, R.; Pol, L. 2017: International Guidelines on Human Rights and Drug Control: A Tool for Securing Women's Rights in Drug Control Policy Health and human rights 19(1): 253-261
Merrifield, N. 2015: NICE issues new guidelines on safe staffing levels for midwives Nursing Times 111(10): 5